{
    "clinical_study": {
        "@rank": "151339", 
        "arm_group": [
            {
                "arm_group_label": "Atherosclerosis", 
                "arm_group_type": "Active Comparator", 
                "description": "coronary artery disease patients with carotid plaques confirmed by a ultrasound study"
            }, 
            {
                "arm_group_label": "control", 
                "arm_group_type": "Sham Comparator", 
                "description": "no coronary artery disease patients without carotid plaques confirmed by a ultrasound study"
            }
        ], 
        "brief_summary": {
            "textblock": "Until now, no specific atherosclerosis-targeting agent labeled with positron emitter is not\n      yet available. Investigators developed neomannosyl human serum albumin(MSA) for the terminal\n      mannose residues of MSA binding with the mannose receptors of macrophages in\n      atherosclerosis, and investigators investigate whether 68Ga-MSA can be a novel agent for\n      non-invasive molecular imaging of carotid atherosclerotic lesion in PET."
        }, 
        "brief_title": "Visualization of Carotid Atherosclerosis by 68Ga-MSA", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Atherosclerosis", 
            "Carotid Atherosclerosis", 
            "Noninvasive Imaging of Atherosclerosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atherosclerosis", 
                "Coronary Artery Disease", 
                "Carotid Artery Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2022coronary artery disease patients with carotid plaques\n\n               -  control without carotid plaque\n\n        Exclusion Criteria:\n\n          -  \u2022pregnancy, allergy to albumin, any acute or chronic inflammatory disease,\n             hematologic disease, liver disease, renal disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01893489", 
            "org_study_id": "Ga_MSA_CAD_carotid"
        }, 
        "intervention": {
            "arm_group_label": [
                "Atherosclerosis", 
                "control"
            ], 
            "description": "68Gallium-MSA 2.0 mci for Positron Emission Tomogram(PET) imaging", 
            "intervention_name": "68Gallium-MSA", 
            "intervention_type": "Other", 
            "other_name": "68Gallium-MSA"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "positron emission tomography", 
            "macrophage", 
            "neomannosyl human serum albumin"
        ], 
        "lastchanged_date": "August 23, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "152-703"
                    }, 
                    "name": "Korea University Guro Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of", 
                        "zip": "110-744"
                    }, 
                    "name": "Department of Nuclear Medicine, Institute of Radiation Medicine,"
                }
            }
        ], 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Phase I Study to Evaluated the Safety of Noninvasive Molecular Imaging for the Detection of Inflammation in Carotid Atherosclerotic Lesions by Using Ga-68-NOTA-MSA in Healthy Volunteers and Patients With Coronary Artery Disease", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "development of unexpected skin rashes or other skin lesions at  MSA injection site of the skin with 2 hours after MSA injection", 
                "measure": "side reactions at MSA injection site of the skin", 
                "safety_issue": "Yes", 
                "time_frame": "with 2 hours after MSA injection"
            }, 
            {
                "description": "This includes unstable changes of vital signs including blood pressure, body temperature and heart rate, and abnormal changes of biochemical parameters such as hematologic, hepatic and renal functions.", 
                "measure": "unstable changes of vital signs and development of abnormal biochemical parameters", 
                "safety_issue": "Yes", 
                "time_frame": "24 hours after MSA injection"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01893489"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Korea University", 
            "investigator_full_name": "Hong Seog Seo", 
            "investigator_title": "Professor of Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "standard uptake unit(SUV) at carotid arteries", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }, 
            {
                "measure": "SUV at aorta and iliac arteries", 
                "safety_issue": "No", 
                "time_frame": "baseline"
            }
        ], 
        "source": "Korea University", 
        "sponsors": {
            "collaborator": {
                "agency": "SHIN JIN MEDICS", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Korea University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}